FDA data updated: April to June 2026
The site recorded this update on . A count that is different is not a statement about a product. A report does not show that a drug or a device caused the event.
What changed
- FDA changed counts for April to June 2026 in a later export.
- 1 drug page has a different count.
- 1 page is new.
Drug pages
The rows are in order of name. The order says nothing about a product. Each row has two counts and the quarter of each count.
FDA says:
Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.
Source: openFDA, Drug Adverse Event Overview. The site read the page on .
The information in these reports cannot be used to estimate the incidence (occurrence rates) of the events reported.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .
| Name | Count before, April to June 2026 | Count now, April to June 2026 |
|---|---|---|
| Bupropion hydrochloride | 232 | 222 |
| Bupropion Hydrochloride XL | new page |
A page is in a table when search engines can index it and the earlier count or the new count is 10 or more. Each other page shows its own change.